Literature DB >> 11581307

Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance.

A E Pugh-Bernard1, G J Silverman, A J Cappione, M E Villano, D H Ryan, R A Insel, I Sanz.   

Abstract

The study of human B cell tolerance has been hampered by difficulties in identifying a sizable population of autoreactive B lymphocytes whose fate could be readily determined. Hypothesizing that B cells expressing intrinsically autoreactive antibodies encoded by the VH4-34 heavy chain gene (VH4-34 cells) represent such a population, we tracked VH4-34 cells in healthy individuals. Here, we show that naive VH4-34 cells are positively selected and mostly restricted to the follicular mantle zone. Subsequently, these cells are largely excluded from the germinal centers and underrepresented in the memory compartment. In healthy donors but not in patients with systemic lupus erythematosus (SLE), these cells are prevented from differentiating into antibody-producing plasma cells. This blockade can be overcome ex vivo using cultures of naive and memory VH4-34 cells in the presence of CD70, IL-2, and IL-10. VH4-34 cells may therefore represent an experimentally useful surrogate for autoantibody transgenes and should prove valuable in studying human B cell tolerance in a physiological, polyclonal environment. Our initial results suggest that both positive and negative selection processes participate in the maintenance of tolerance in autoreactive human B cells at multiple checkpoints throughout B cell differentiation and that at least some censoring mechanisms are faulty in SLE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11581307      PMCID: PMC200949          DOI: 10.1172/JCI12462

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  79 in total

1.  Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens.

Authors:  S B Hartley; J Crosbie; R Brink; A B Kantor; A Basten; C C Goodnow
Journal:  Nature       Date:  1991-10-24       Impact factor: 49.962

Review 2.  Clonal deletion of autospecific B lymphocytes.

Authors:  D Nemazee; D Russell; B Arnold; G Haemmerling; J Allison; J F Miller; G Morahan; K Buerki
Journal:  Immunol Rev       Date:  1991-08       Impact factor: 12.988

Review 3.  Human immunoglobulin heavy-chain variable region genes: organization, polymorphism, and expression.

Authors:  V Pascual; J D Capra
Journal:  Adv Immunol       Date:  1991       Impact factor: 3.543

4.  Structural characterization of the second major cross-reactive idiotype group of human rheumatoid factors. Association with the VH4 gene family.

Authors:  G J Silverman; R E Schrohenloher; M A Accavitti; W J Koopman; D A Carson
Journal:  Arthritis Rheum       Date:  1990-09

5.  Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotype.

Authors:  V Pascual; K Victor; D Lelsz; M B Spellerberg; T J Hamblin; K M Thompson; I Randen; J Natvig; J D Capra; F K Stevenson
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

6.  Human monoclonal antibodies against blood group antigens preferentially express a VH4-21 variable region gene-associated epitope.

Authors:  K M Thompson; J Sutherland; G Barden; M D Melamed; I Randen; J B Natvig; V Pascual; J D Capra; F K Stevenson
Journal:  Scand J Immunol       Date:  1991-10       Impact factor: 3.487

7.  Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice.

Authors:  J Erikson; M Z Radic; S A Camper; R R Hardy; C Carmack; M Weigert
Journal:  Nature       Date:  1991-01-24       Impact factor: 49.962

8.  Selective expression of a VHIV subfamily of immunoglobulin genes in human CD5+ B lymphocytes from cord blood.

Authors:  R A Mageed; L E MacKenzie; F K Stevenson; B Yuksel; F Shokri; B R Maziak; R Jefferis; P M Lydyard
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

9.  A transgenic model of autoimmune hemolytic anemia.

Authors:  M Okamoto; M Murakami; A Shimizu; S Ozaki; T Tsubata; S Kumagai; T Honjo
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

10.  Most peripheral B cells in mice are ligand selected.

Authors:  H Gu; D Tarlinton; W Müller; K Rajewsky; I Förster
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

View more
  127 in total

1.  Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation.

Authors:  Jacob Glanville; Tracy C Kuo; H-Christian von Büdingen; Lin Guey; Jan Berka; Purnima D Sundar; Gabriella Huerta; Gautam R Mehta; Jorge R Oksenberg; Stephen L Hauser; David R Cox; Arvind Rajpal; Jaume Pons
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

2.  Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.

Authors:  Millaray Marincevic; Mahmoud Mansouri; Meena Kanduri; Anders Isaksson; Hanna Göransson; Karin Ekström Smedby; Jesper Jurlander; Gunnar Juliusson; Fred Davi; Kostas Stamatopoulos; Richard Rosenquist
Journal:  Haematologica       Date:  2010-08-26       Impact factor: 9.941

3.  High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors.

Authors:  Millaray Marincevic; Nicola Cahill; Rebeqa Gunnarsson; Anders Isaksson; Mahmoud Mansouri; Hanna Göransson; Markus Rasmussen; Mattias Jansson; Fergus Ryan; Karin Karlsson; Hans-Olov Adami; Fred Davi; Jesper Jurlander; Gunnar Juliusson; Kostas Stamatopoulos; Richard Rosenquist
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

4.  Identification of a B cell signature associated with renal transplant tolerance in humans.

Authors:  Kenneth A Newell; Adam Asare; Allan D Kirk; Trang D Gisler; Kasia Bourcier; Manikkam Suthanthiran; William J Burlingham; William H Marks; Ignacio Sanz; Robert I Lechler; Maria P Hernandez-Fuentes; Laurence A Turka; Vicki L Seyfert-Margolis
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

5.  CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells.

Authors:  Jennifer Huggins; Tina Pellegrin; Raymond E Felgar; Chungwen Wei; Miguel Brown; Bo Zheng; Eric C B Milner; Steven H Bernstein; Ignacio Sanz; Martin S Zand
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

Review 6.  Immunological tolerance as a barrier to protective HIV humoral immunity.

Authors:  Kristin Ms Schroeder; Amanda Agazio; Raul M Torres
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

Review 7.  Beyond regulatory T cells: the potential role for IL-2 to deplete T-follicular helper cells and treat autoimmune diseases.

Authors:  André Ballesteros-Tato
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

8.  Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells.

Authors:  Nai-Ying Zheng; Kenneth Wilson; Xiaojian Wang; Angela Boston; Grant Kolar; Stephen M Jackson; Yong-Jun Liu; Virginia Pascual; J Donald Capra; Patrick C Wilson
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

9.  An entity evolving into a community: defining the common ancestor and evolutionary trajectory of chronic lymphocytic leukemia stereotyped subset #4.

Authors:  Lesley-Ann Sutton; Giorgos Papadopoulos; Anastasia Hadzidimitriou; Stavros Papadopoulos; Efterpi Kostareli; Richard Rosenquist; Dimitrios Tzovaras; Kostas Stamatopoulos
Journal:  Mol Med       Date:  2015-04-02       Impact factor: 6.354

Review 10.  B cells and immunological tolerance.

Authors:  Nataly Manjarrez-Orduño; Tâm D Quách; Iñaki Sanz
Journal:  J Invest Dermatol       Date:  2009-02       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.